OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tolerability profile of paliperidone palmitate formulations: A pharmacovigilance analysis of the EUDRAVigilance database
Giuseppe Cicala, Renato de Filippis, María Antonietta Barbieri, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 8

Showing 8 citing articles:

Evaluating the 6-month formulation of paliperidone palmitate: a twice-yearly injectable treatment for schizophrenia in adults
Giovanna Cirnigliaro, Vera Battini, Michele Castiglioni, et al.
Expert Review of Neurotherapeutics (2024) Vol. 24, Iss. 4, pp. 325-332
Closed Access | Times Cited: 5

Schizophrenia and Related Psychoses

(2025), pp. 1-278
Closed Access

Safety of Dual Orexin Receptor Antagonist Daridorexant: A Disproportionality Analysis of Publicly Available FAERS Data
Giuseppe Cicala, María Antonietta Barbieri, Giulia Russo, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 3, pp. 342-342
Open Access | Times Cited: 3

Effectiveness of SGA-LAIs on Clinical, Cognitive, and Social Domains in Schizophrenia: Results from a Prospective Naturalistic Study
Renato de Filippis, Filippo Antonio Staltari, Matteo Aloi, et al.
Brain Sciences (2023) Vol. 13, Iss. 4, pp. 577-577
Open Access | Times Cited: 9

Safety of Dual Orexin Receptor Antagonist Daridorexant: A Dispropor-tionality Analysis of Publicly Available FAERS Data
Giuseppe Cicala, María Antonietta Barbieri, Giulia Russo, et al.
(2024)
Open Access | Times Cited: 1

Neuropsychiatric Adverse Events with Monoclonal Antibodies Approved for Multiple Myeloma: An Analysis from the FDA Adverse Event Reporting System
Giuseppe Cicala, Giulia Russo, Vincenza Santoro, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 10, pp. 1266-1266
Open Access | Times Cited: 1

Safety of Inclisiran: A Disproportionality Analysis from the EudraVigilance Database
Giuseppe Cicala, Michelangelo Rottura, Viviana Maria Gianguzzo, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 10, pp. 1365-1365
Open Access | Times Cited: 1

Proposing a novel approach for the long-term use of monthly paliperidone palmitate: adjusting injection dose versus adjusting injection interval
Sergio Sánchez Alonso, Enrique Baca‐García, Santiago Ovejero, et al.
Expert Opinion on Drug Metabolism & Toxicology (2024) Vol. 20, Iss. 8, pp. 709-712
Open Access

Page 1

Scroll to top